{[ promptMessage ]}

Bookmark it

{[ promptMessage ]}

04 - Proceedings of the 49th Annual ASTRO Meeting for these...

Info iconThis preview shows page 1. Sign up to view the full content.

View Full Document Right Arrow Icon
for these patients. They are generally treated by simple palliative techniques; whole brain XRT and chemotherapy with or without chest XRT. Considering the possibility of less advanced disease and better performance status of this group of NSCLC patients compared to those who develop brain metastases after their initial diagnosis, we performed a retrospective study to determine whether aggressive treatments to brain, lung or both is beneficial in disease control and/or survival. Materials/Methods: The cases of 75 patients presenting with non-small cell lung carcinoma with synchronous brain metastases treated between 1998-2002 were reviewed at Upstate Medical University at Syracuse. Patients were assessed for aggressive treat- ment to the brain with either craniotomy or gamma knife radiosurgery and aggressive treatment to the primary lung cancer with surgery, chemoradiation therapy or both. Results: Median follow-up was 15 months. 43 patients received aggressive treatment to brain, 20 received aggressive treatment to lung and 45 patients had palliative treatment. 21 patients recurred in the brain, (10/43 in aggressive treatment group, 11/36 palli- ative group). 9 patients recurred or demonstrated progressive disease in the lung (1/12 aggressive treatment group, 8/63 in non- aggressive group). The median survival was 7.9 months for the entire cohort, 8.4 months in the aggressive treatment group and 7.7 months in the non-aggressive treatment group ( p = 0.44). There were 10 long-term survivors living more than 2 years. 2 of
Background image of page 1
This is the end of the preview. Sign up to access the rest of the document.

{[ snackBarMessage ]}

Ask a homework question - tutors are online